How the Analysis of the Pathogenetic Variants of DDR Genes Will Change the Management of Prostate Cancer Patients
Alessandro Sciarra(Policlinico Umberto I), Stefano Salciccia(Policlinico Umberto I), Giovanni Battista Di Pierro(Policlinico Umberto I), Marco Frisenda(Sapienza University of Rome), Susanna Cattarino(Policlinico Umberto I), Paolo Casale(Humanitas University), Gianna Mariotti(Policlinico Umberto I), Riccardo Autorino(Rush University Medical Center), Pietro Viscuso(Policlinico Umberto I), Benjamin I. Chung(Stanford Medicine), Francesco Del Giudice(Sapienza University of Rome), Simone Crivellaro(University of Illinois Chicago), Giulio Bevilacqua(Policlinico Umberto I), Alessandro Gentilucci(Policlinico Umberto I)
Cited by 8
Related Papers
Factors contributing to healthcare professional burnout during the COVID-19 pandemic: A rapid turnaround global survey
|PLoS ONE|2020|556
Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non–muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection
|European Urology|2019|212
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
|Annals of Oncology|2009|205
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
|International Journal of Molecular Sciences|2022|190